Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.

Por Allal, A. S., Alonso-Pentzke, L., Remadi, S.
Publicado em 1998

Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy

Por Allal, A S, Gervaz, P, Bründler, M-A
Publicado em 2004

Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck

Por Mhawech, P, Dulguerov, P, Tschanz, E, Verdan, C, Ares, C, Allal, A S
Publicado em 2004

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy

Por Allal, A S, Sprangers, M A G, Laurencet, F, Reymond, M A, Kurtz, J M
Publicado em 1999

Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential

Por Roth, A D, Berney, C R, Rohner, S, Allal, A S, Morel, P, Marti, M-C, Aapro, M S, Alberto, P
Publicado em 2000

Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes

Por Allal, A S, Bieri, S, Pelloni, A, Spataro, V, Anchisi, S, Ambrosetti, P, Sprangers, M A G, Kurtz, J M, Gertsch, P
Publicado em 2000